Search by Drug Name or NDC
NDC 59148-0053-98 Nuedexta 20; 10 mg/1; mg/1 Details
Nuedexta 20; 10 mg/1; mg/1
Nuedexta is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Otsuka America Pharmaceutical, Inc. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE.
Product Information
NDC | 59148-0053 |
---|---|
Product ID | 59148-053_99646f6f-58d9-4f4b-a17f-f4d43288ff4a |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Nuedexta |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | dextromethorphan hydrobromide and quinidine sulfate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE, GELATIN COATED |
Route | ORAL |
Active Ingredient Strength | 20; 10 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
Labeler Name | Otsuka America Pharmaceutical, Inc |
Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021879 |
Listing Certified Through | 2024-12-31 |
Package
NDC 59148-0053-98 (59148005398)
NDC Package Code | 59148-053-98 |
---|---|
Billing NDC | 59148005398 |
Package | 4 CARTON in 1 BOX (59148-053-98) / 1 BOTTLE in 1 CARTON (59148-053-07) / 13 CAPSULE, GELATIN COATED in 1 BOTTLE |
Marketing Start Date | 2023-01-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |